 | |
 | |
| Clinical data | |
|---|---|
| Other names | 2C-D-5-EtO; 2CD-5-EtO; 5-Ethoxy-2-methoxy-4-methylphenethylamine; 2-Methoxy-5-ethoxy-4-methylphenethylamine; 4-Methyl-2-methoxy-5-ethoxyphenethylamine; 2-Methoxy-4-methyl-5-ethoxyphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| Pharmacokinetic data | |
| Onset of action | ~2 hours (peak)[1] |
| Duration of action | 12 hours[1][2][3] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO2 |
| Molar mass | 209.289 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
2CD-5EtO, also known as5-ethoxy-2-methoxy-4-methylphenethylamine, is apsychedelic drug of thephenethylamine,2C, andTWEETIO families related to2C-D.[1][2][3] It is theanalogue of 2C-D in which themethoxy group at the 5 position has been extended to anethoxy group.[1][2][3]
In his bookPiHKAL (Phenethylamines I Have Known and Loved) and other publications,Alexander Shulgin lists 2CD-5EtO's dose as 40 to 50 mgorally, itsonset as slow and gradual, its time to peak or full effects as about 2 hours, and itsduration as 12 hours.[1][2][3] The effects of 2CD-5EtO were said to include being "largely free from excitement", having "a friendly openness and outgoingness that allowed easy talk, interaction, humor", and allowing for healthy appetite.[1]
Thechemical synthesis of 2CD-5EtO has been described.[1]
2CD-5EtO was first described in the literature byAlexander Shulgin in his bookPiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1] It was developed and tested byDarrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7]
2CD-5EtO is acontrolled substance inCanada under phenethylamine blanket-ban language.[8]
